Advertisement
Screener

Haemonetics Corporation (HAE) Investment Income, Interest

2.6 / 5 stars · 48/93 Roast Me

Haemonetics Corporation Investment Income, Interest

Haemonetics Corporation (HAE) reported Investment Income, Interest of $106.00 thousand for the 3-month period ending 2011-07-02, per its 10-Q filed 2011-08-10.

Discontinued › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2011-08-10

  • Haemonetics Corporation investment income, interest for the quarter ending 2011-07-02 was $106.00K, a 3.92% increase year-over-year.
  • Haemonetics Corporation investment income, interest for the quarter ending 2011-04-02 was $83.00K, a 7.78% decline year-over-year.
  • Haemonetics Corporation investment income, interest for the quarter ending 2011-01-01 was $91.00K, a 62.50% increase year-over-year.
  • Haemonetics Corporation investment income, interest for the quarter ending 2010-10-02 was $493.00K, a 378.64% increase year-over-year.
  • Haemonetics Corporation investment income, interest for fiscal 2011 was $384.00K, a 3.76% decline from fiscal 2010.
  • Haemonetics Corporation investment income, interest for fiscal 2010 was $399.00K, a 79.73% decline from fiscal 2009.
  • Haemonetics Corporation investment income, interest for fiscal 2009 was $1.97M.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 6 monthInvestment Income, Interest 9 monthInvestment Income, Interest 12 month
2011-07-02$106.00K
10-Q · filed 2011-08-10
$189.00K
derived: sum of 2 quarters · filed 2011-08-10
$280.00K
derived: sum of 3 quarters · filed 2011-08-10
$773.00K
derived: sum of 4 quarters · filed 2011-08-10
2011-04-02$83.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-05-26
$174.00K
derived: sum of 2 quarters · filed 2011-05-26
$667.00K
derived: sum of 3 quarters · filed 2011-05-26
$384.00K
10-K · filed 2011-05-26
2011-01-01$91.00K
10-Q · filed 2011-02-08
$584.00K
derived: sum of 2 quarters · filed 2011-02-08
$301.00K
10-Q · filed 2011-02-08
$776.00K
derived: sum of 4 quarters · filed 2011-08-10
2010-10-02$493.00K
10-Q · filed 2010-11-10
$460.00K
10-Q · filed 2010-11-10
$685.00K
derived: sum of 3 quarters · filed 2011-08-10
$741.00K
derived: sum of 4 quarters · filed 2011-08-10
2010-07-03$102.00K
10-Q · filed 2011-08-10
$192.00K
derived: sum of 2 quarters · filed 2011-08-10
$248.00K
derived: sum of 3 quarters · filed 2011-08-10
$351.00K
derived: sum of 4 quarters · filed 2011-08-10
2010-04-03$90.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-05-26
$146.00K
derived: sum of 2 quarters · filed 2011-05-26
$249.00K
derived: sum of 3 quarters · filed 2011-05-26
$399.00K
10-K · filed 2011-05-26
2009-12-26$56.00K
10-Q · filed 2011-02-08
$159.00K
derived: sum of 2 quarters · filed 2011-02-08
$309.00K
10-Q · filed 2011-02-08
2009-09-26$103.00K
10-Q · filed 2010-11-10
$253.00K
10-Q · filed 2010-11-10
2009-06-27$157.00K
10-Q · filed 2010-08-11
2009-03-28$1.97M
10-K · filed 2011-05-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55